Table 3.
Baseline patient characteristics
|
Control |
Intervention |
|
|---|---|---|
| (n = 70) | (n = 58) | |
| Mean age (range) |
58 (41 – 74) |
57 (41 – 78) |
| White race |
56% |
53% |
| Education: |
70% |
65% |
| At least some college | ||
| Marital Status: |
59% |
64% |
| Married | ||
| Personal Doctor |
96% |
96% |
| FH of Prostate Cancer |
13% |
4% |
| Discussed PSA with MD in last 12 months |
51% |
41% |
| Prior MD recommendation for screening |
22% |
14% |
| Previous PSA Screening (ever) |
59% |
44% |
| Previous Abnormal PSA |
10% |
7% |
| Plan for PSA Screening in next 12 months |
80% |
69% |
| Think PSA Screening is a Decision |
17% |
34% |
| Have Key Knowledge about PSA Decision* |
10% |
3% |
| Preferred Participation in DM: |
|
|
| I decide |
16% |
25% |
| Share decision |
77% |
71% |
| MD decides |
7% |
4% |
| Decisional Conflict, uncertainty score (sd)† | 1.9 (0.8) | 1.9 (0.8) |
*Key knowledge: Agreement with the following four statements: 1) Some men can live long lives with prostate cancer, 2) most men diagnosed as prostate cancer die of something else, 3) problems with sexual function is a common side effect of prostate cancer treatments, and 4) problems with urination is a common side effect of prostate cancer treatments.
†Decisional Conflict, uncertainty score: Mean agreement on 1–5 scale for the following 3 questions: 1) The decision is easy for me to make, 2) I am sure what to do in this decision, 3) It is clear what choice is best for me.